ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Simple Search Results

Didn't find what you were looking for? Try the Advanced Search »

  • « Previous Page
  • 1
  • …
  • 60
  • 61
  • 62
  • 63
  • 64
  • …
  • 96
  • Next Page »
Search Again »
  • Abstract Number: 0326 • ACR Convergence 2025

    Gender Disparities in Clinical Outcomes Among Older Adults with Knee Osteoarthritis: A Retrospective Cohort Study

    Kinga Grzybowski1, Ahmer Khan2, Samuel Bonomo3 and Arthur Lau4, 1Jefferson Einstein Montgomery Hospital, Maspeth, NY, 2Jefferson Einstein Philadelphia Hospital, Philadelphia, 3Jefferson Einstein Montgomery Hospital, East Norriton, PA, 4Jefferson Einstein Hospital, Maple Glen, PA

    Background/Purpose: Osteoarthritis (OA) is the most common type of arthritis which classically affects multiple joints, mainly the knees. About 595 million people worldwide suffer from…
  • Abstract Number: 0331 • ACR Convergence 2025

    Safety and Efficacy of Colchicine in Osteoarthritis: A Systematic Review and Meta-Analysis of 6,965 Patients

    Mohamed Abdelsalam1, Bassant Elaraby Elsayed Badwy2, Menat Alla Ayman Ali Mahdy2, Maryam Lasheen3, Hadeer Hafez4, Omar Sameh Nabil El Sedafy1 and Mohamed Reda Awad5, 1Misr University For Science and Technology, 6 october, Al Jizah, Egypt, 2Misr University For Science and Technology, Nasr City, Al Qahirah, Egypt, 3Misr University For Science and Technology, Helwan, Al Qahirah, Egypt, 46th October University, 6 october, Al Jizah, Egypt, 5Al Azhar University, Cairo, Egypt, Giza, Al Jizah, Egypt

    Background/Purpose: Osteoarthritis (OA) is the most common joint disease, that leads to significant pain and affects quality of life, particularly in older adults. Current treatments…
  • Abstract Number: 0463 • ACR Convergence 2025

    Synovial fluid is a robust biomarker of synovial tissue inflammation in rheumatoid arthritis

    Solana Cushing1, Susan Goodman2, Michael Parides1, Hadeel Abdul-Rehman1, Daniel Ramirez2, Edward DiCarlo2, Kristine Carandang3, Renee Davis4, Rebecca Blank5, Laura Donlin1, Anna Helena Jonsson6, Amit Lakhanpal2, Bella Mehta7, Dana Orange8 and Melanie smith2, 1Hospital for Special Surgery, New York, NY, 2Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 3Young Patients' Autoimmune Research & Empowerment Alliance, San Diego, CA, 4New York, New York, NY, 5NYU Langone Health, New York, NY, 6University of Colorado School of Medicine, Aurora, CO, 7Hospital for Special Surgery, Weill Cornell Medicine, Jersey City, NJ, 8The Rockefeller University, New York, NY

    Background/Purpose: Synovial tissue pathotype may indicate treatment response in RA, but synovial biopsies are not widely available. Synovial fluid (SF) is a promising surrogate. We…
  • Abstract Number: 0526 • ACR Convergence 2025

    Identification of Urine Proteomic Biomarkers Associated with Ankylosing Spondylitis

    Chang-Nam Son1, Dong-Ki Jang2, So-Hye Nam3, Yoon-Jeong Oh4, Sungsin Jo5, Jong-Seo Kim6 and Tae-Hwan Kim7, 1UIJEONGBU EULJI MEDICAL CENTER, EULJI UNIVERSITY, UIJEONGBU, Republic of Korea, 2School of Biological Sciences, Seoul National University, Seoul, Republic of Korea, 3Division of Rheumatology, Department of Internal Medicine, School of Medicine, Keimyung University, Daegu, Republic of Korea, 4Uijeongbu Eulji Medical Center, Eulji University School of Medicine, Uijeongbu, Republic of Korea, 5Department of Biology, Soonchunhyang University, Asan,, Republic of Korea, 6School of Biological Sciences, Seoul National University, Seoul, 7Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea

    Background/Purpose: Currently available diagnostic tests for inflammatory arthritis lack sufficient sensitivity and specificity, often requiring the integration of clinical manifestations with physician expertise for accurate…
  • Abstract Number: 0817 • ACR Convergence 2025

    More than 40% of Older Adults with Rheumatic Diseases Are Prescribed Opioid Medications

    Christine Anastasiou1, Eric Roberts2, gabriela Schmajuk3 and Jinoos Yazdany4, 1Stanford University, Pleasanton, CA, 2University of California, San Francisco, SF, CA, 3University of California, San Francisco, and San Francisco Veterans Affairs Medical Center, San Francisco, CA, 4UCSF, San Francisco, CA

    Background/Purpose: Patients with rheumatic diseases commonly experience acute or chronic pain that may lead to both short- and long-term opioid use. Many patients do not…
  • Abstract Number: 0830 • ACR Convergence 2025

    Rheum2Listen: Leveraging Podcasts to Teach Rheumatology to Internal Medical Residents

    Nikita Ivanov1, Beeta Shasti-Nazem2, Moriah Gottman1 and Sonam Kiwalkar3, 1Legacy Emanuel Internal Medicine Residency Program, Portland, OR, 2Legacy Salmon Creek Internal Medicine Residency Program, Vancouver, WA, 3The Vancouver Clinic, Portland, OR

    Background/Purpose: Podcasts are an increasingly popular tool in medical education, shown to match or exceed traditional lectures in short term retention and learner satisfaction. Despite…
  • Abstract Number: 1008 • ACR Convergence 2025

    Nationwide Historical Cohort Study on the Primary Prophylactic Effects of Colchicine in Cardiovascular Events

    Hasan Satis1, Umut Kalyoncu2, Gizem Ayan3, Ali Aykut Fidanci4, Mustafa Mahir Ulgu4, Naim Ata4, Suayip Birinci4, Mehmet Koçak5 and Ahmet Gul6, 1University of Health Sciences, Abdurrahman Yurtaslan Oncology Hospital, Rheumatology, Ankara, Turkey, 2Division of Rheumatology, Department of Internal Medicine, Hacettepe University School of Medicine, Ankara, Turkey, Ankara, Turkey, 3Ankara Research and Training Hospital, Ankara, Turkey, 4Ministry of Health, Ankara, Turkey, 5Medipol University, Istanbul, Turkey, 6Istanbul University, Istanbul, Turkey

    Background/Purpose: While two trials with colchicine have demonstrated its efficacy in reducing the risk of cardiovascular events, a more recent study showed no significant impact…
  • Abstract Number: 1117 • ACR Convergence 2025

    Inflammatory Arthritis after Hematopoietic Stem Cell Transplant: A Case Series and Literature Review

    Scott Yeudall1, Mark Levis2, Jonathan Webster2 and Laura Cappelli3, 1The Johns Hopkins Hospital, Baltimore, MD, 2Johns Hopkins University School of Medicine, Baltimore, MD, 3Johns Hopkins School of Medicine, Baltimore, MD

    Background/Purpose: Hematopoietic stem cell transplant (HSCT) is a commonly employed treatment for hematologic malignancies including acute leukemias and lymphomas but can be complicated by graft-versus-host…
  • Abstract Number: 1131 • ACR Convergence 2025

    Variant Drives Tophus Formation through Dual Mechanisms: Extracellular Aggregation andvImpaired Macrophage Phagocytic Clearance

    Yuqi wang1, Lingjiang Zhu1, Jinshuo Han2, Junbin Qian3, Martin Herrmann4, Jing Xue1 and Lei Liu1, 1The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China (People's Republic), 2Zhejiang University, School of Medicine, Hangzhou, China (People's Republic), 3Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China (People's Republic), 4University Hospital Erlangen, Erlangen, Germany

    Background/Purpose: While aggregated neutrophil extracellular traps (aggNETs) constitute the primary structural component of tophi, the susceptible population for tophaceous gout remains poorly characterized. We investigated…
  • Abstract Number: 1133 • ACR Convergence 2025

    A Proteomic Analysis Of Subclinical Synovial Inflammation Associated With Monosodium Urate Crystal Deposition

    Mariano Andrés1, María-Luisa Peral-Garrido2, Samanta Ortuño3, Rocío Caño3, Silvia Gómez-Sabater3, Alejandra Bermúdez4, Teresa Lozano5, Miguel Perdiguero5, elena Caro-Martínez6, Ruth Sánchez-Ortiga5, Carolina Ruiz-García7, Eliseo Pascual8 and Rubén Francés8, 1Dr Balmis Alicante General University Hospital-ISABIAL, Alicante, Spain, 2Vinalopó University Hospital, Novelda, Spain, 3Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain, 4Rheumatology Department, Dr. Balmis General University Hospital, Alicante, Spain., Alicante, Spain, 5Dr Balmis General University Hospital, Alicante, Spain, 6HACLE San Vicente Hospital, San Vicente del Raspeig, Spain, 7Campoamor Health Center, Alicante, Spain, 8Miguel Hernandez University of Elche, Alicante, Spain

    Background/Purpose: Persistent subclinical inflammation from monosodium urate (MSU) crystals is present in gout and asymptomatic hyperuricemia (AH). The underlying mechanism is poorly understood. This study…
  • Abstract Number: 1140 • ACR Convergence 2025

    PGG Suppresses MSU Crystal–Triggered Inflammation and Arachidonic Acid Production in PBMCs

    Sadiq Umar1, Poorna Chandra Rao Yalagala2, Sugasini Dhavamani2 and Sriram Ravindran2, 1University of Illinois at Chicago, Chicago, IL, 2University of Illinois, Chicago, IL

    Background/Purpose: Gout is the most prevalent inflammatory arthritis globally, with rising incidence in both developed and developing regions. It is driven by monosodium urate (MSU)…
  • Abstract Number: 1141 • ACR Convergence 2025

    Modulation of Inflammatory Responses by Dental Pulp Stem Cell Extracellular Vesicles in Monosodium Urate-Stimulated Macrophages

    Sadiq Umar1, Kasey Leung2 and Sriram Ravindran2, 1University of Illinois at Chicago, Chicago, IL, 2University of Illinois, Chicago, IL

    Background/Purpose: Gout is the most prevalent form of inflammatory arthritis, with rising global incidence. It results from the deposition of monosodium urate (MSU) crystals in…
  • Abstract Number: 1477 • ACR Convergence 2025

    Can Large Language Models Support Clinical Decision-Making in Atypical SLE? A Comparative Analysis

    Beste Acar1, Berkay Aktas1, Oguzhan Omer Kizilkaya1, Zekayi Kutlubay2 and serdal Ugurlu3, 1Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey, 2Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Department of Dermatology, Istanbul, Turkey, Istanbul, Istanbul, Turkey, 3Istanbul University-Cerrahpasa, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey

    Background/Purpose: This study evaluates the contributions of large language models (LLMs) in clinical decision-making for atypical presentations of systemic lupus erythematosus (SLE). It focuses on…
  • Abstract Number: 1649 • ACR Convergence 2025

    Does Physical Activity Differ Among those with Autoimmune vs Non-Autoimmune Rheumatic Diseases?

    Sydney Liles1, Jennifer Copson2, Yvonne Lee3 and Daniel K. White1, 1University of Delaware, Newark, DE, 2University of Delaware, Wilmington, DE, 3Northwestern University, Chicago, IL

    Background/Purpose: Individuals with rheumatic conditions, such as Rheumatoid Arthritis (RA) and Osteoarthritis (OA), often experience low physical activity levels. Physical activity may vary by autoimmune…
  • Abstract Number: 1668 • ACR Convergence 2025

    A clinically validated assay for rapid determination of type I and type II interferon activity in pediatric inflammatory diseases

    Evan Hsu1, Courtney Leson2, Amrita Basu3, Michael Lam4, Jian Yue4, Casey Rimland5, Rachel Weng4, Lauren Henderson6, Joyce Chang2, Mary Beth Son4, Fatma Dedeoglu4, roshini Abraham3 and Pui Lee1, 1Boston Children's Hospital, Newton, MA, 2Boston Children's Hospital, Boston, 3Nationwide Children's Hospital, Columbus, OH, 4Boston Children's Hospital, Boston, MA, 5Brigham and Women's Hospital, Boston, 6Boston Children's Hospital, Watertown, MA

    Background/Purpose: Type I interferons (IFN-I) and type II interferon (IFN-g) are essential to host defense but dysregulated production of these cytokines is increasingly recognized in…
  • « Previous Page
  • 1
  • …
  • 60
  • 61
  • 62
  • 63
  • 64
  • …
  • 96
  • Next Page »
Search Again »

Didn't find what you were looking for? Try the Advanced Search »

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology